Table 1 Description of patients and controls
RATL patients | LATL patients | BILATL patients | Control subjects | |
|---|---|---|---|---|
N | 10 | 17 | 8 | 80 |
Age (mean ± S.D.) | 66.4 ± 6.9 | 68.7 ± 5.7 | 68.0 ± 6.5 | 69.4 ± 10.7 |
Sex (female to male) | 4:6 | 12:5 | 4:4 | 39:41 |
Education * | 12.6 ± 2.9 | 14.0 ± 2.9 | 12.9 ± 3.3 | N.A |
Symptom duration, years (mean ± S.D.)** | 2.8 ± 1.6 | 3.2 ± 2.2 | 3.0 ± 1.8 | N.A |
MMSE score ** | 23.4 ± 5.4 | 23.3 ± 3.7 | 23.8 ± 1.8 | N.A |
Amyloid PET (Proportion of negative from all available cases) | 5/5 | 8/8 | 6/6 | N.A |
Predominant clinical symptoms | Behavioral: 8 Language: 1 Other: 1 | Behavioral: 2 Language: 10 Memory: 5 | Behavioral: 2 Language: 3 Memory: 3 | N.A |